EQT Infrastructure to acquire Icon Group, Australia’s largest integrated cancer care provider
- EQT Infrastructure has agreed to acquire Icon Group from a consortium including Goldman Sachs Asset Management, QIC and Pagoda. Goldman Sachs Asset Management will remain a minority shareholder as part of the transaction - Icon Group is Australia's largest vertically integrated cancer care provider, offering radiation oncology, medical oncology, compounding and pharmacy services through a network of facilities across...
Investment Confidence in Icon Group to Drive Next Phase of Global Growth With EQT Infrastructure Investment
BRISBANE, Australia, Nov. 19, 2021 /PRNewswire/ -- Icon Group has today announced it will enter the next phase of global expansion of its transformative integrated cancer care model following the investment of global investment organisation EQT. The investment demonstrates confidence in the strength of the business, delivering a significant outcome for the healthcare company. EQT is a purpose-driven...
Antengene Announces IND Approval in China for a Phase I/II Study of Selinexor (ATG-010) in Patients with Non-Hodgkin Lymphoma
SHANGHAI and Hong Kong, Nov. 19, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and oncology, today announced that the China National Medical Products Administration (NMPA) has approved a single-arm dose-finding Phase I/II study...
Tavotek Biotherapeutics Announces Completion of Round B Financing with $35 Million
LOWER GWYNEDD, Penn., Nov. 19, 2021 /PRNewswire/ -- Tavotek Biotherapeutics, a fast-growing biotech company, announces it has raised $35M in Round B financing. CS Capital, a leading private equity fund manager in China, led this finance round followed by Fontus Capital. This round of financing will be used to accelerate the Phase 1 clinical development of several antibody drugs to start in early 2022. The upcoming antibody drugs...
250,000 times sharper vision – Biometric progressive lenses offer pin-sharp vision in every direction of gaze
MUNICH, Nov. 18, 2021 /PRNewswire/ -- Our eyes do an enormous amount of work every day and are constantly moving – up to 250,000 times a day. Biometric progressive lenses from Rodenstock assist the eye in every single one of these up to a quarter of a million daily eye movements and...
Lunit’s AI Software for Breast Cancer Detection, Lunit INSIGHT MMG, Wins FDA Clearance
SEOUL, South Korea, Nov. 18, 2021 /PRNewswire/ -- Lunit, a leading medical AI provider, today announced that the US Food and Drug Administration (FDA) 510(k) has cleared its AI solution for breast cancer detection, 'Lunit INSIGHT MMG'. Along with its chest x-ray triaging solution 'Lunit INSIGHT CXR Triage', the company's AI solution...
JBS is entering the cultivated protein market with the acquisition of BioTech Foods and the construction of a plant in Europe
The new production plant in Spain will scale up production. The Company is also going to build a research & development center in biotechnology and cultivated protein in Brazil. The investments total US$100 million SÃO PAULO, Nov. 18, 2021 /PRNewswire/ -- JBS, the largest global protein company and the world's second-largest food industry, has entered into an agreement to acquire...
Betagenon co-founder publishes study demonstrating that pan-AMPK activator O304 acts as an exercise mimetic in aged mice
STOCKHOLM, Nov. 18, 2021 /PRNewswire/ -- Betagenon AB, a Sweden-based company focused on development of AMPK activator compounds, today announced the publication by co-founder Prof. Helena Edlund of a new study demonstrating that in aged mice the pan-AMPK activator O304 improves cardiac function and exercise capacity, while preventing and reversing age-associated hyperinsulinemia and insulin resistance. O304 thus functions as...
The Sigourney Award-2021 Honors Three Recipients With Distinguished International Prize for Advancing Psychoanalytic Thought
SEATTLE, Nov. 18, 2021 /PRNewswire/ -- The Sigourney Award annually rewards achievements that advance psychoanalytic thought and practice with international recognition and a substantial cash prize. This year, a panel of distinguished judges evaluated applications from five continents for The Sigourney Award-2021. The work recognized represents significant advancement of psychoanalytic thought. Today, William...
Development of “VR hands on training” with hand tracking in live-action medical VR!
TOKYO, Nov. 18, 2021 /PRNewswire/ -- Jolly Good Inc. (Chuo-ku, Tokyo, CEO: Kensuke Joji; "Jolly Good") has developed the "VR hands on training" function as a new feature of the "OPECloud VR hands on training system". This is a VR clinical training platform developed and provided by Jolly Good, where hand tracking sensors are used to superimpose the VR...
